It includes a profile of what such a vaccine would accomplish and the different research areas needed.
The Centers for Disease Control and Prevention (CDC) today ended its investigation into a multistate outbreak of Salmonella Montevideo linked to raw sprouts.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, today weighed in on steps the FDA it taking to improve the effectiveness of seasonal flu vaccines, which includes collaborating with partners at the Centers for Medicare and Medicaid Services (CMS) to use a large database that includes information on flu vaccines given to 4 million people.
One of the changes involves H3N2, a move that will likely not solve egg-adaptation problems, an expert says.
After careful deliberation, experts approved the nasal-spray vaccine 12-2.
As researchers work on solving the complex puzzle of all the factors that influence flu vaccine effectiveness (VE), researchers today report that low VE of the H3N2 component during the 2012-13 flu season may have been due to poor immune response rather than adaptations in egg-grown vaccine viruses, as previously thought.
The proposed law would direct $200 million a year for 5 years to research.
Protection is 36% overall, 25% against H3N2, 67% against H1N1, and 42% against flu B.
The high-dose flu vaccine is 38% more effective in protecting elderly people against laboratory-confirmed influenza than the standard-dose vaccine, according to a study of Veterans Health Administration (VHA) senior patients published yesterday in the Journal of Infectious Diseases.
China has reported the world's first known novel H7N4 avian flu infection in a human, according to a report today from Hong Kong's Centre for Health Protection (CHP), which based its information on a notification from the mainland's National Health and Family Planning Commission.
